Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Mayo Clinic
Mayo Clinic
Khon Kaen University
University of Chicago
Montefiore Medical Center
Mayo Clinic
University of Southern California
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center